For: | Guo J, Dong B, Ji JF, Wu AW. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients. World J Gastroenterol 2012; 18(38): 5434-5441 [PMID: 23082061 DOI: 10.3748/wjg.v18.i38.5434] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i38/5434.htm |
Number | Citing Articles |
1 |
Na Kong, Wendong Li, Jun Zhang, Xin Wang, Lin Hu, Qiqi Xu. TRPM8 as a Potential Biomarker and Therapeutic Target for Gastric
Cancer Identified by a Combination of Text Mining and RNA Sequencing. Current Gene Therapy 2023; 23(5): 391 doi: 10.2174/1566523223666230529142423
|
2 |
Yuyan Gong, Hongwei He, Hong Liu, Caixia Zhang, Wuli Zhao, Rong-guang Shao. Phosphorylation of myofibrillogenesis regulator‐1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cells. FEBS Letters 2014; 588(17): 2903 doi: 10.1016/j.febslet.2014.07.018
|
3 |
Wenxia Zhao, Yang Li, Hanzeng Cheng, Mengyan Wang, Zhishuo Zhang, Meilian Cai, Cong Zhao, Xiaoming Xi, Xiaojun Zhao, Wuli Zhao, Yajun Yang, Rongguang Shao. Myofibrillogenesis Regulator‐1 Regulates the Ubiquitin Lysosomal Pathway of Notch3 Intracellular Domain Through E3 Ubiquitin‐Protein Ligase Itchy Homolog in the Metastasis of Non‐Small Cell Lung Cancer. Advanced Science 2024; 11(15) doi: 10.1002/advs.202306472
|
4 |
Chang-Yong Zhao, Zi-Jian Guo, Sai-Min Dai, Yong Zhang, Jun-Jing Zhou. Clinicopathological and prognostic significance of myofibrillogenesis regulator-1 protein expression in pancreatic ductal adenocarcinoma. Tumor Biology 2013; 34(5): 2983 doi: 10.1007/s13277-013-0862-4
|
5 |
Junxia Wang, Wuli Zhao, Hong Liu, Hongwei He, Rongguang Shao. Myofibrillogenesis regulator 1 (MR-1): a potential therapeutic target for cancer and PNKD. Journal of Drug Targeting 2018; 26(8): 643 doi: 10.1080/1061186X.2017.1401077
|
6 |
Xin-Ying Han, Hong-Zheng Liu, Chun-Yi Cai, Xiu-Qing Li, Ying-Bo Ju, Yan-Yan Li, Zhi-Gang Zhang. Expression of VGLL4 and YAP protein in gastric carcinoma tissues and tumor prognosis. Minerva Medica 2018; 109(6) doi: 10.23736/S0026-4806.18.05692-6
|